Sold on the high on Fridaym waiting for a dip, and buying CONX ---The most recent grant was awarded to Corgenix and members of the Viral Hemorrhagic Fever Consortium (VHFC), a collaboration of academic and industry members headed by Tulane University. The NIH phase II, R44 grant was awarded to Corgenix and VHFC to develop rapid diagnostic tests (RDT) for Ebola, enabling rapid response to public health and bioterrorism threats posed by the deadly virus. Corgenix and the VHFC have previously developed and CE marked the ReLASV® rapid test for the Lassa fever virus.
SO, you think this is its bottom, Down with everything else tomorrow.IMO --Happy if you bought it at 55 a year or so again when it crashed by 60% +/-,
Read when asked about research on EBOLA, they are keeping mum, Seems like they have the equipment, now we need them to use it on this deadly disease. . . back burner the other development for a month or two, imo
While we wait, I'm putting more into APT !, moving up with Ebola news-- Hospital and all care givers need protection, Orders are going nuts!! Should be good for 3 -5 dollars or more IMHO, Best to all those holding ACAD and KERX for the GO sign!!!!!!!!!!!!!!!!!!!!!
Sentiment: Strong Buy